Talk to a public procurement expert
company logo

Licitaciones a Incyte Biosciences Iberia, S.L

Learn about Incyte Biosciences Iberia, S.L's profile as a public procurement awardee.

Tenders

112
Awarded: 112
In progress: 0
Unawarded: 0

Budgets

4.176.795 €
Awarded amount: 4.176.795 €
Minor contracts: 580.405 €
Estimated value: 6.075.294 €

Averages

42.620 €
Discount rate: 0%
Number of bidders: 1,0
Number of lots: 0

Organizations

16
Successful bidders: 1
Minor contracts: 103

View complete and updated information

To access all detailed and updated information about this tender, access our Tendios platform.

Access Tendios

Top 5 Contracting organizations

LogoSERVICIO ANDALUZ DE SALUD86
LogoInstitut Català de la Salut (ICS)4
LogoConsejería de Sanidad··>Servicio Madrileño de Salud··>Dirección General Asistencial··>Gerencia Asistencial de Hospitales··>Hospital Universitario Príncipe de Asturias4
LogoConsejería de Sanidad··>Servicio Madrileño de Salud··>Dirección General Asistencial··>Gerencia Asistencial de Hospitales··>Hospital Universitario La Paz3
LogoConsejería de Sanidad··>Servicio Madrileño de Salud··>Dirección General Asistencial··>Gerencia Asistencial de Hospitales··>Hospital Universitario 12 de Octubre2

Top 5 Bidders

LogoIncyte Biosciences Iberia, S.L112

Top 5 CPVs

🩺Equipamiento y artículos médicos, farmacéuticos y de higiene personal93
💊Productos farmacéuticos91
💊Medicamentos diversos3
💊Medicamentos usados en dermatología y para el sistema muscular-esquelético1
💉Medicamentos usados en dermatología1

Top 5 Budgets

CONTRACT OBJECTBASE BUDGETDETAILS

Suministro de Ponatinib (DOE)...

1.278.720 € View more

Suministro de ponatinib (doe)...

1.278.720 € View more

HUJ_1CBAM_AM 376/2025_INCYTE_SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS XI I(RELACION...

651.000 € View more

Suministro del medicamento cuyo principio activo es ponatinib para el complejo a...

181.152 € View more

P.N.S.P. 20/2025. Suministro del medicamento exclusivo: Ruxolitinib (OPZELURA)...

112.387,5 € View more

Latest tenders won by Incyte Biosciences Iberia, S.L - Febrero 2026

Be the first to know about all tenders to Incyte Biosciences Iberia, S.L in the last 12 months.

CONTRACT OBJECTBASE BUDGETFILE NUMBERDETAILS

TAFASITAMAB 200MG/INYECTABLE IV-Forma farmacéutica:INYECTABL...

⏱️ Offer submission deadline: 14 ene 17:00

6510 € CONTR20250000427287View more

HUJ_1CBAM_AM 376/2025_INCYTE_SUMINISTRO DE MEDICAMENTOS EXCL...

⏱️ Offer submission deadline: 5 ene 12:37

651.000 € CONTR20250000680121View more

Suministros ( cca. +ia83g8)

⏱️ Offer submission deadline: 1 ene 23:00

407.608.472,63 € CONTR20250000445996View more

RUXOLITINIB 15MG/G, G CREMA

⏱️ Offer submission deadline: 16 dic 17:16

12.487,5 € CONTR20250000593877View more

RUXOLITINIB 15MG/G, G CREMA

⏱️ Offer submission deadline: 16 dic 15:10

6243,75 € CONTR20250000578673View more

Other Bidders

Explore More Related Content

🏛️

Contracting Organizations

Discover the public organizations this company has worked with and their main contracts.

View organizations
📍

Tenders by Location

Explore the tenders available in Spain where this company could participate.

View tenders in Spain
🏢

Specialization Sectors

Learn about the sectors where this company has more experience and success in tenders.

Explore sectors
📋

Frequent CPV Codes

Review the most used CPV codes in the tenders this company has won.

View CPV codes
⚔️

Direct Competition

Analyze other bidding companies in the same sector to understand the competitive landscape.

View competition
📈

Market Trends

Stay up to date with the latest trends in public procurement and emerging opportunities.

View trends